Denosumab trials for Osteoporosis

All Denosumab trials · All Osteoporosis trials

Phase breakdown

Recruiting trials studying Denosumab for Osteoporosis

• Clinical Relevance of Modifying RANKL Signaling During Folliculogenesis
  NCT07546552 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: Female · 1 location
• Markers of Osteoporosis in Cystic Fibrosis
  NCT03921060 · Phase: Phase 4 · Ages: 18 Years to 64 Years · Sex: All (male and female) · 1 location
• RANK-ligand Inhibition to Combat Sarcopenia with Underlying Osteoporosis
  NCT06643780 · Phase: Phase 4 · Ages: 65 Years and older · Sex: All (male and female) · 1 location
• Romosozumab and Denosumab, Alone or Combined, in Postmenopausal Osteoporosis
  NCT07283887 · Phase: Phase 4 · Ages: 50 Years to 80 Years · Sex: Female · 1 location
• Sequential Therapies After Osteoanabolic Treatment
  NCT06164795 · Phase: Not specified · Ages: 50 Years to 85 Years · Sex: Female · 8 locations
• Study of the Key Techniques of Prevention and Treatment of Osteoporotic Refracture
  NCT05866029 · Phase: Not applicable (e.g. observational or device study) · Ages: 45 Years to 90 Years · Sex: All (male and female) · 58 locations
• The Effect of Denosumab on Muscle and Strength and Insulin Sensitivity
  NCT07271771 · Phase: Phase 4 · Ages: 40 Years and older · Sex: Female · 1 location

Common questions

How many trials study Denosumab for Osteoporosis?

7 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.